The Danish Pre-HCQ COVID Dialysis Study

Summary

Hydroxychloroquine has been shown to inhibit replication of SARS-CoV-2 in vitro. The presented multicenter parallel-group open-label randomized clinical trial aims to investigate the efficacy of prophylactic hydroxychloroquine on mitigation of risk of hospitalization due to COVID-19 in patients with end-stage renal disease.

Timeline

Start

2020-04-10

Primary completion

2020-07-31

Completion

2020-10-01

Drugs

Indications